The favorable effect of NOD2 on suppressing tumor and increasing chemosensitivity of HCC is reported here for the first time, which may indicate novel therapeutic strategy against HCC based on the modulation of NOD2. The gene discussed is NOD2; the disease is hepatocellular carcinoma.